New award for ropinirole tablets with marlex pharmaceuticals. Period of performance is august 28, 2021 to august 27, 2022 with four one-year options.
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79721D0043
- Awardee
-
Marlex Pharmaceuticals Inc. UEI VSSNJEFMPLB3
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Ropinirole Tablets (VA-21-00043762) Pre-Solicitation · 36E79721R0030 · Posted Apr 1, 2021
- 6505--Ropinirole Tablets Effective 9/28/2021 - 9/27/2022 Award Notice · Posted Jun 28, 2021
- 6505--Ropinirole Tablets (VA-21-00043762) Solicitation · Posted Apr 14, 2021
- Last date to order 100% complete
- IDV ceiling
- $14,787,656.00
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV award is for a single-award Indefinite Delivery Contract (IDC) with Marlex Pharmaceuticals Inc., a minority-owned, small disadvantaged business. The contract, valued at $14,787,656.00, is for the supply of Ropinirole HCL tablets in various dosages to the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The period of performance is from August 28, 2021, to August 27, 2022, with four one-year option periods. This IDC was awarded by the VA National Acquisition Center, a civilian federal agency, and is designed to provide an uninterrupted source of supply for these generic pharmaceutical products to support federal healthcare programs. The original pre-solicitation notice outlined the estimated annual requirements for each Ropinirole tablet dosage, ranging from 5,519 bottles of the 5mg tablets to 108,616 bottles of the 1mg tablets, with the intent to award a single contract to the responsible offeror capable of meeting the government's needs.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79721D0043?
36E79721D0043 was awarded to Marlex Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on September 28, 2021.
How much is contract 36E79721D0043 worth?
36E79721D0043's own ceiling is $14,787,656.
Who can order from contract 36E79721D0043?
36E79721D0043 is a single award indefinite delivery contract.
Was contract 36E79721D0043 competed?
The extent of competition for 36E79721D0043 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV